Opendata, web and dolomites

DO-IT SIGNED

Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "DO-IT" data sheet

The following table provides information about the project.

Coordinator
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE 

Organization address
address: Houghton Street 1
city: LONDON
postcode: WC2A 2AE
website: www.lse.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.bd4bo.eu
 Total cost 7˙191˙755 €
 EC max contribution 3˙549˙833 € (49%)
 Programme 1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2))
 Code Call H2020-JTI-IMI2-2015-07-two-stage
 Funding Scheme IMI2-CSA
 Starting year 2017
 Duration (year-month-day) from 2017-02-01   to  2019-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE UK (LONDON) coordinator 1˙263˙850.00
2    IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG SE (LUND) participant 453˙440.00
3    SEMMELWEIS EGYETEM HU (BUDAPEST) participant 359˙918.00
4    NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE UK (MANCHESTER) participant 298˙788.00
5    TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV DE (BERLIN) participant 231˙190.00
6    FOLKEHELSEINSTITUTTET NO (OSLO) participant 186˙240.00
7    IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE UK (LONDON) participant 169˙776.00
8    TANDVARDS-OCH LAKEMEDELSFORMANSVERKET SE (STOCKHOLM) participant 149˙000.00
9    THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL BE (BRUXELLES) participant 120˙745.00
10    UNIVERSITA COMMERCIALE LUIGI BOCCONI IT (MILANO) participant 119˙921.00
11    EUROPEAN CANCER PATIENT COALITION BE (BRUXELLES) participant 100˙644.00
12    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 96˙321.00
13    AMGEN BE (Bruxelles) participant 0.00
14    ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA ES (MADRID) participant 0.00
15    BAYER AKTIENGESELLSCHAFT DE (Leverkusen) participant 0.00
16    BOEHRINGER INGELHEIM INTERNATIONALGMBH DE (INGELHEIM) participant 0.00
17    CELGENE MANAGEMENT SARL CH (BOUDRY) participant 0.00
18    Eli Lilly and Company Limited UK (Basingstoke) participant 0.00
19    F. HOFFMANN-LA ROCHE AG CH (BASEL) participant 0.00
20    FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES BE (BRUXELLES) participant 0.00
21    GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. UK (BRENTFORD) participant 0.00
22    HEALTH IQ LIMITED UK (LONDON) participant 0.00
23    INSTITUT DE RECHERCHES INTERNATIONALES SERVIER FR (SURESNES) participant 0.00
24    INTERSYSTEMS GMBH DE (DARMSTADT) participant 0.00
25    JANSSEN PHARMACEUTICA NV BE (BEERSE) participant 0.00
26    MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN DE (DARMSTADT) participant 0.00
27    MERCK SHARP & DOHME CORP US (WHITEHOUSE STATION NJ) participant 0.00
28    NOVARTIS PHARMA AG CH (BASEL) participant 0.00
29    NOVO NORDISK A/S DK (BAGSVAERD) participant 0.00
30    PFIZER LIMITED UK (SANDWICH) participant 0.00
31    SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT FR (Chilly Mazarin) participant 0.00
32    STATENS LEGEMIDDELVERK NO (OSLO) participant 0.00
33    THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY UK (LONDON) participant 0.00
34    THE UNIVERSITY OF LIVERPOOL UK (LIVERPOOL) participant 0.00
35    UCB BIOPHARMA SRL BE (BRUXELLES) participant 0.00
36    VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV DE (Berlin) participant 0.00

Map

 Project objective

The overall goal of the Big Data for Better Outcomes (BD4BO) programme is to facilitate the use of ‘big data’ to promote the development of value-based, outcomes-focused healthcare systems in Europe. To fully exploit the transformative potential of big data, consideration will need to be taken of the use of detailed personal and biological information across the spectrum of care delivery, starting from the development of innovative medicines and treatments, to market access and adoption, diffusion, and use in healthcare systems by providers and patients. This paradigm shift requires shared understanding and standards among healthcare stakeholders including patients, providers, payers, regulators, policy makers, pharmaceutical industry, and academia.

OBJECTIVES The proposed Coordination and Support Action (CSA) will establish an enabling platform that brings together these stakeholder groups across the BD4BO programme to ensure quality and consistency of individual projects in line with the overarching programme objective. Our consortium therefore aims to promote the use of big Data for better Outcomes, policy Innovation and healthcare system Transformation (DO->IT). Accordingly, we will: • Define a programme strategy that ensures quality, consistency and sustainability of health outcomes related activities across individual BD4BO projects. • Integrate, synthesise, and manage knowledge from all BD4BO projects, making it easily accessible via a single knowledge exchange platform. • Act as pivotal point of collaboration, stakeholder engagement and communication for all BD4BO projects. • Provide transparency and enable the use of patient health data and human biological samples for research purposes by developing minimum data privacy standards for Informed Consent Forms (ICFs) and supporting materials for use by individual BD4BO disease-specific projects and more widely in the Research and Development (R&D) sector.

 Deliverables

List of deliverables.
Narrative: The consortium narrative that communicates the purpose of the BD4BO programme Documents, reports 2020-04-08 21:28:29
Level 2 Biobanking ICF Documents, reports 2020-04-08 21:28:28
Continous exchange with external data privacy related stakeholders (DPECs, BD4BO projects, other related data privacy initiatives) Other 2020-04-08 21:28:28
Run DPEC-R F2F workshop to collect input on critical data privacy topics Other 2020-04-08 21:28:28
Level 2 Clinical ICF Documents, reports 2020-04-08 21:28:29
Level 3 Non-Clinical ICF Documents, reports 2020-04-08 21:28:29
Training Materials for patients and to increase awareness about R&D, and to clarify essential aspects of data privacy laws and regulations in R&D Documents, reports 2020-04-08 21:28:29
Level 3 Biobanking ICF Documents, reports 2020-04-08 21:28:29
Level 2 Non-Clinical ICF Documents, reports 2020-04-08 21:28:28
Explanatory Information on minimum data privacy standards for ICFs for clinical studies, non-clinical studies and biobanking incl. focus group’ feedback on the Clinical ICF, Non-Clinical ICF and Biobanking ICF Documents, reports 2020-04-08 21:28:29
DPEC-O F2F workshop to collect input on critical data privacy topics Other 2020-04-08 21:28:29
Level 1 Clinical ICF based on T4.1.1, T4.2.1 and D4.15 Documents, reports 2020-04-08 21:28:29
Establish unmet ‘big data’ data needs of the health care system Documents, reports 2020-04-08 21:28:28
Set up the infrastructure and maintenance required for the communications and outreach plans; refer to deliverable descriptions for the type of activities that will be implemented Other 2020-04-08 21:28:28
Level 3 Clinical ICF Documents, reports 2020-04-08 21:28:28
Establish and coordinate engagement with International Advisory Board (IAB) and Data Protection & Ethics Committee (DPEC) Other 2020-04-08 21:28:28
Establish Data Privacy and Ethics Committees (DPECs): - Operational-DPEC (DPEC-O) - Regulatory-DPEC (DPEC-R) Other 2020-04-08 21:28:28
Develop interim/short-term strategic guidance document Documents, reports 2020-04-08 21:28:28
Summary of the empirical investigation results, including proposal on method in order to integrate survey results Documents, reports 2020-04-08 21:28:28
Develop a targeted outreach plan for external collaboration with stakeholders Documents, reports 2020-04-08 21:28:28
Interim guidance document for existing BD4BO projects on approach proposed by the Distributed Data Network working group Documents, reports 2020-04-08 21:28:28

Take a look to the deliverables list in detail:  detailed list of DO-IT deliverables.

 Publications

year authors and title journal last update
List of publications.
2017 Michel Van Speybroeck (Janssen), Michael Arend (Bayer), Jeremy Hayter (Pfizer), Joachim Marti (Imperial College London), Anthouny Rowe (Janseen), Jerry Lanfear (Pfizer)
Interim guidance document for existing BD4BO projects on approach proposed by the Distributed Data Network working group
published pages: , ISSN: , DOI:
2020-04-08
2017 Myriam Drysdale, Marianne Cunningham and Bart Barefoot(GlaxoSmithKline); Fredrik Moen from the Swedish Institute of Health; Tino Melzer (Bayer); Irene Schluender (TMF);Michel Van Speybroeck (Janssen); Michael Arend (Bayer); Jeremy Hayter (Pfizer); Joachim Marti (Imperial College London); Anthony Rowe (Janssen);Jerry Lanfear (Pfizer);Carmen Fenollosa (LSE);László Bencze (Semmelweis University);Heather Stegenga, (NICE);Stephan Korte (Novartis)
Interim strategic guidance document
published pages: , ISSN: , DOI:
2020-04-08
2017 Maximilian Salcher
Connecting the dots: putting big data to work for health systems
published pages: 3-6, ISSN: 1356-1030, DOI:
EuroHealth 2017; Vol. 23(1): 2020-04-08
2017 Miklós Szócska, Sahan Jayawardana, Carin Smand, Tayyab Salimullah, Catherine Reed and Shahid Hanif
Big Data for Better Outcomes: Supporting Health Care System Transformation in Europe
published pages: 7-9, ISSN: 1356-1030, DOI:
EuroHealth 2017; Vol. 23(1): 2020-04-08
2018 Ciani O1, Meregaglia M2, Jayawardana S3, Carney C3, Salcher M3, Williamson P41Centre for Research on Health and Social Care Management (CERGAS), Bocconi University, Milan, Italy, 2Bocconi University, Milan, Italy, 3London School of Economics and Political Science, London, UK, 4University of Liverpool, Liverpool, UK
CliniCal Core outComes sets in real World data
published pages: 112, ISSN: , DOI:
VALUE IN HEALTH Journal 2020-04-08

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DO-IT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DO-IT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.7.)

EBOVAC3 (2018)

Bringing a prophylactic Ebola vaccine to licensure

Read More  

TRIC-TB (2019)

Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments.

Read More  

PD-MIND (2019)

Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug

Read More